| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/24/2010 | US20100158971 Method for reducing the likelihood of preeclampsia in a subject in need thereof |
| 06/24/2010 | US20100158910 Treatment of renal cell carcinoma with anti-cd70 antibody-drug conjugates |
| 06/23/2010 | EP2198876A1 A method for reducing the likelihood of implantation failure in a subject |
| 06/23/2010 | EP2198875A1 A method for reducing the likelihood of preterm labour in a subject in need thereof |
| 06/23/2010 | EP1441747B1 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition |
| 06/23/2010 | CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 06/23/2010 | CN1821236B Therapeutic heterocyclic compounds |
| 06/23/2010 | CN101745112A Treatment of TNFalpha related disorders |
| 06/22/2010 | US7741340 Hydroxy piperidine derivatives to treat gaucher disease |
| 06/22/2010 | US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation |
| 06/22/2010 | US7741305 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease |
| 06/22/2010 | US7740834 Murine zcytor17 ligand polypeptides |
| 06/22/2010 | US7740463 Pressurised metered dose inhalers (MDI) |
| 06/22/2010 | CA2216963C Tie-2 ligands, methods of making and uses thereof |
| 06/17/2010 | US20100152149 Formulation |
| 06/17/2010 | US20100151006 Cancer therapy sensitizer |
| 06/17/2010 | US20100150968 Dna vectors |
| 06/17/2010 | US20100150925 Treatment of b-cell cancers with anti-cd70 antibody-drug conjugates |
| 06/16/2010 | EP2196544A1 Kit for ligation detection assays using codeable labels |
| 06/16/2010 | EP2196210A1 A method for reducing the likelihood of preeclampsia in a subject in need thereof |
| 06/16/2010 | CN1984921B Modulation of survivin expression |
| 06/16/2010 | CN1982308B Substituted pyrazoles |
| 06/16/2010 | CN1829711B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing them |
| 06/16/2010 | CN1809364B Compositions and methods for increasing telomerase activity |
| 06/16/2010 | CN1694871B Imidazolopyridines and methods of making and using the same |
| 06/16/2010 | CN101735212A Controlled synthesis of ziprasidone and compositions thereof |
| 06/16/2010 | CN101735131A New salts |
| 06/15/2010 | US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury |
| 06/15/2010 | US7737250 Peptides for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons |
| 06/15/2010 | US7736639 Using water-soluble polymer conjugated interleukin-18 as therapeutic in treatment and prevention of cell proliferative disorders |
| 06/15/2010 | US7736370 Method for interconnecting longitudinal members extending along a spinal column |
| 06/15/2010 | CA2379103C Novel spiro compounds |
| 06/10/2010 | US20100144858 Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| 06/10/2010 | US20100144611 Treatment of t-cell mediated diseases |
| 06/10/2010 | US20100143485 Oxycontin controlled release formulations and methods of using same |
| 06/10/2010 | US20100143355 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 06/10/2010 | US20100143338 Treatment of t-cell mediated diseases |
| 06/09/2010 | EP2193808A1 Synergistic combination |
| 06/09/2010 | EP1572744B1 Immunoglobulin variants and uses thereof |
| 06/09/2010 | CN101723948A C-6 modified indazolylpyrrolotriazines |
| 06/09/2010 | CN101721697A Anti-cancer and anti-infectious disease compositions and methods for using same |
| 06/09/2010 | CN101721402A treating bone-related disorders with selective androgen receptor modulators |
| 06/08/2010 | US7732592 ALK protein tyrosine kinase, cells and methods embodying and using same |
| 06/08/2010 | US7732486 Anhydrous silver dihydrogen citrate compositions |
| 06/08/2010 | US7732476 contacting target cell, which expresses mutant type or wild type autophosphorylated (p) FLT-3 tyrosine kinase, with N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2(E)-propenamide, and concomitantly contacting cell with 4-benzoyl staurosporine; flow cytometry |
| 06/08/2010 | US7732467 Administering the dihydropyridine calcium channel antagonist, nilvadipine to treat a cerebral amyloidogenic disease, such as Alzheimer's disease, transmissible spongiform encephalopathy, scrapie, traumatic brain injury, cerebral amyloid angiopathy and Gerstmann-Straussler-Scheinker syndrome |
| 06/08/2010 | US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis |
| 06/08/2010 | US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 06/08/2010 | US7732432 such as (11 beta ,16 beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl ethylcarbamate, having potent antiinflammatory and immunosuppressive activity and possess advantages over steroidal glucocorticoid ligands with respect to side effects, efficacy, toxicity and/or metabolism |
| 06/08/2010 | US7732415 Topical treatment or prevention of ocular infections |
| 06/08/2010 | US7732403 Treatment of T-cell mediated diseases |
| 06/08/2010 | US7731967 Compositions for inducing immune responses |
| 06/08/2010 | CA2266053C Tint composition for keratin fibers containing a direct cationic dye and a substance-based polymer |
| 06/03/2010 | US20100137950 System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| 06/03/2010 | US20100137583 Peptidomimetic protease inhibitors |
| 06/03/2010 | US20100137271 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 06/03/2010 | US20100137243 Oxazolidinone And/Or Isoxazoline As Antibacterial Agents |
| 06/03/2010 | US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 06/03/2010 | US20100137198 Pharmaceutical composition for topical application |
| 06/03/2010 | US20100136105 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 06/03/2010 | US20100136056 Novel insertion sites in pox vectors |
| 06/03/2010 | US20100136043 Composition comprising immunogenic microparticles |
| 06/03/2010 | US20100136011 Antibodies that bind to obm |
| 06/02/2010 | EP2191846A1 Method for treating pain by administering a nerve growth factor antagonist and an NSAID and composition containing the same |
| 06/02/2010 | EP1553937B1 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv |
| 06/02/2010 | CN101054345B Novel bensophenone derivatives or salts thereof |
| 06/01/2010 | US7728169 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| 06/01/2010 | US7727995 Antiherpes drug combinations |
| 06/01/2010 | US7727969 Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
| 06/01/2010 | US7727564 Jucara and açai fruit-based dietary supplements |
| 06/01/2010 | US7727466 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer |
| 05/27/2010 | US20100129293 Near Infrared Imaging Agent |
| 05/26/2010 | EP1613345B1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 05/26/2010 | EP1596809B1 Abeta binding molecules |
| 05/26/2010 | CN1751064B Hsp60 from arthrobacter |
| 05/26/2010 | CN1744913B Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 05/26/2010 | CN1744902B Pharmaceutical combination for the treatment of cancer |
| 05/26/2010 | CN1713907B N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors |
| 05/26/2010 | CN1684668B Sustained release delivery of amphetamine salts |
| 05/26/2010 | CN1681386B Compositions and products containing s-equol, and methods for their making |
| 05/26/2010 | CN1671412B Immunostimulatory compositions and methods of stimulating an immune response |
| 05/26/2010 | CN1468308B Anti-TNF antibodies, compositions, methods and uses |
| 05/26/2010 | CN1391469B Npyy5拮抗剂 Npyy5 antagonist |
| 05/25/2010 | US7723508 Modulation of apolipoprotein (A) expression |
| 05/25/2010 | US7723474 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 05/25/2010 | US7723470 Antibiotic of given structure; vancomycin derivatives; enhanced activity, selectivity and reduced mammalian toxicity |
| 05/25/2010 | US7723373 3-(Aryl or heteroaryl)sulfonyl- or sulfinyl-1-indoleacetic acid derivatives, e.g., 3 -[(4-chlorophenyl)sulfonyl]-2,5-dimethyl-1H-indol-1-acetic acid; treating asthma, rhinitis and other diseases in which raised levels of PGD2 or its metabolites |
| 05/25/2010 | US7723349 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions |
| 05/25/2010 | US7723288 Methods and compositions for the treatment of neurological disease |
| 05/25/2010 | US7723087 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 05/25/2010 | US7723021 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases |
| 05/25/2010 | CA2245890C Use of an extract of cimicifuga racemosa |
| 05/20/2010 | US20100124536 Hemophilia Treatment by Inhalation of Coagulation Factors |
| 05/19/2010 | EP1759013B1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 05/19/2010 | EP1115382B1 Immunogenic liposome compositions |
| 05/18/2010 | US7718762 stimulate T cytotoxic lymphocytes in a mammal |
| 05/18/2010 | US7718746 Anion-binding polymers and uses thereof |
| 05/18/2010 | US7718412 comprising a continuous, biocompatible liquid phase, a solid phase comprising porous or non-porous particles of a biocompatible polymer suitable for use in hemostasis and which are substantially insoluble in the liquid phase, and sterile thrombin |
| 05/18/2010 | US7718363 Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
| 05/18/2010 | US7718163 Includes additive material on the surfaces of the carrier particles to promote the release of the active particles from the carrier particles on actuation of the inhaler; an inhalant includes crystalline milk sugar carrier,leucine additive and beclomethasone dipropionate inhalant |